Discover a comprehensive guide to Non-Invasive Prenatal Testing (NIPT), the most advanced and safest method for screening genetic conditions like Down syndrome, Edwards syndrome, and Patau syndrome. Using a maternal blood sample from as early as 10 weeks, NIPT offers highly accurate, non-invasive detection of chromosomal abnormalities. Learn how it works, its benefits, and limitations!
Non-Invasive Prenatal Testing (NIPT)
The Most Advanced and Safest Screening Method for Genetic Conditions
Non-Invasive Prenatal Testing (NIPT)
During pregnancy, fragments of fetal DNA circulate in the mother’s bloodstream and can be detected as early as the 7th week of gestation. As pregnancy progresses, the concentration of cell-free fetal DNA (cffDNA) in maternal blood increases, becoming sufficient by the 10th week to deliver highly accurate and sensitive NIPT results. Using a simple maternal blood sample, NIPT enables the detection of chromosomal abnormalities, structural genetic variations in the developing fetus.
NIPT utilizes a pregnant woman’s blood to screen for fetal chromosomal disorders. The test analyzes cell-free DNA to assess the risk of conditions such as Down syndrome (Trisomy 21). Importantly, NIPT is a screening — not a diagnostic — test. It provides healthcare providers with a probability score indicating the likelihood of a chromosomal condition, rather than a definitive diagnosis. This test can be performed starting at 10 weeks of gestation.
What Is Non-Invasive Prenatal Testing (NIPT)?
NIPT stands for Non-Invasive Prenatal Testing. It is a highly sensitive prenatal screening performed during pregnancy to evaluate the risk of specific chromosomal abnormalities in the fetus, including:
- Down syndrome (Trisomy 21)
- Edwards syndrome (Trisomy 18)
- Patau syndrome (Trisomy 13)
- Sex chromosome aneuploidies (e.g., Turner, Klinefelter, Triple X, and XYY syndromes)
- Fetal sex determination (optional)
The test is performed by drawing a small blood sample from the mother. This sample contains cell-free DNA fragments originating from the placenta, which closely reflect the fetal genetic profile. DNA carries genetic instructions organized into chromosomes; analyzing it allows clinicians to gain insight into the fetus’s chromosomal composition.
The blood sample is sent to a specialized laboratory where advanced sequencing technologies assess the risk for specific chromosomal conditions.
It is important to note that NIPT cannot detect all chromosomal or genetic disorders. It focuses primarily on common aneuploidies and select microdeletions, depending on the testing panel used.
NIPT is also known as cell-free DNA screening (cfDNA) or Non-Invasive Prenatal Screening (NIPS). Remember: NIPT estimates risk — it does not provide a diagnosis. Confirmatory diagnostic testing (such as amniocentesis or chorionic villus sampling) is required for definitive results. NIPT is optional, and your healthcare provider will discuss all available prenatal genetic screening options with you to support informed decision-making.
What Does NIPT Screen For?
NIPT does not screen for all chromosomal abnormalities or congenital defects. Most standard NIPT panels are designed to detect:
- Down syndrome (Trisomy 21)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome abnormalities (X and Y aneuploidies)
Trisomy and Down Syndrome: Causes and Sex Chromosome Screening
Trisomy and Down syndrome occurs due to the presence of an extra chromosome. Similarly, sex chromosome analysis via NIPT helps determine fetal sex and identifies deviations from the normal chromosomal count (46,XX or 46,XY). The most common sex chromosome aneuploidies include:
- Turner syndrome (45,X)
- Klinefelter syndrome (47,XXY)
- Triple X syndrome (47,XXX)
- XYY syndrome (47,XYY)
Not all NIPT panels screen for the same conditions. It is essential to discuss with your healthcare provider exactly which chromosomal abnormalities your specific test covers, including whether sex chromosome aneuploidies or microdeletions are included in your chosen panel.
Why Is Non-Invasive Prenatal Testing (NIPT) Performed?
NIPT is performed to assess the probability of the fetus having specific chromosomal disorders. Your obstetrician may recommend NIPT if:
- You previously had a child with a chromosomal abnormality
- Ultrasound findings suggest possible fetal anomalies
- Earlier screening tests (e.g., first-trimester combined screening) indicated an increased risk
Historically, the American College of Obstetricians and Gynecologists (ACOG) recommended NIPT only for pregnancies considered high-risk. Today, ACOG recommends offering NIPT to all pregnant individuals, regardless of risk factors, as part of comprehensive prenatal genetic screening options.
Depending on NIPT results, your OB/GYN may recommend diagnostic testing, such as amniocentesis or chorionic villus sampling (CVS) — which can provide a definitive diagnosis of chromosomal conditions.
When Is NIPT Performed During Pregnancy?
NIPT can be performed as early as 10 weeks of gestation and up until delivery. Prior to 10 weeks, the concentration of cell-free fetal DNA (cffDNA) in maternal blood is typically insufficient for reliable analysis.
By week 10, however, fetal DNA fragments are present in adequate quantity to ensure high test accuracy and sensitivity. Early testing allows for timely identification of potential risks, providing sufficient time for confirmatory diagnostic procedures, genetic counseling, or further evaluations if indicated.
How accurate is the non-invasive prenatal test (NIPT)?
The accuracy of the test varies depending on the condition being screened for. Furthermore, some factors such as a twin pregnancy, a pregnancy via a surrogate mother, or obesity may affect the results.
NIPT is approximately 99% accurate in detecting Down syndrome, while its accuracy is slightly lower in detecting Trisomy 18 and 13. In general, NIPT yields fewer false-positive results compared to other screenings like the quad screen.
Is it necessary to have an NIPT test during pregnancy?
No, it is not necessary. It is a personal choice, and it is normal to have questions. Your healthcare provider will discuss all prenatal screening options, including NIPT. Several factors may influence your decision to undergo this test or other genetic screenings. If you are having difficulty making a decision or would like to discuss the details more deeply, a genetic specialist can help you understand the available options and what suits you best.
How is the NIPT test performed?
During the test, a specialist draws a blood sample from you to check for any abnormalities in the fetal DNA. Your DNA is inside your cells, and as they divide and break down, small fragments of DNA are released into the bloodstream. During pregnancy, a small amount of fetal DNA is also present in your blood. The NIPT test examines these fragments, known as cell-free DNA (cfDNA).
The blood sample is usually drawn from a vein in the arm and is then sent to a laboratory to be analyzed for specific conditions.
It is important to know that it takes about 10 weeks for a sufficient amount of fetal DNA to be present in the mother’s blood, which is why the test is not performed before the 10th week of pregnancy.
Are there any risks associated with the non-invasive prenatal test (NIPT)?
NIPT tests are completely safe and pose no risk to the fetus. The procedure only requires drawing a blood sample from the pregnant woman.
- It poses no risk to the fetus.
- It does not increase the risk of miscarriage.
- It causes no physical complications for the mother, aside from what might typically occur during a blood draw (like a minor bruise at the needle site).
However, there are some important points to note:
NIPT is a screening test, not a diagnostic one. This means it provides a probability (a high or low risk) but does not confirm a diagnosis with absolute certainty.
The results can sometimes be inaccurate (a false positive or false negative), particularly in cases of:
- Twin pregnancy.
- Placental issues.
- High maternal weight (obesity), which reduces the proportion of fetal DNA in the blood.
When will I receive the test results?
NIPT results can sometimes take up to two weeks, but they are often available sooner. Your healthcare provider receives the results first and then shares them with you.
What do the NIPT results mean?
Since NIPT is a screening test and not a diagnostic one, it does not give a definitive yes or no answer about whether the fetus has a specific condition. Instead, it indicates whether there is a high or low risk that the fetus has the condition being screened for.
The results can sometimes be difficult to understand, so it is best to consult your healthcare provider to clarify them.
The results are usually given separately for each condition screened. For example, you might have a positive or high-risk result for Trisomy 13, while the result is negative or low-risk for Down syndrome.
There is also a possibility that the test may not yield results due to an insufficient amount of fetal DNA in your blood or difficulty in identifying it. In this case, the test can be repeated in the hope of obtaining a result. Your healthcare provider will be best able to guide you in such situations.
How are NIPT results evaluated?
NIPT results determine the risk level for the presence of certain chromosomal abnormalities in the fetus. The test specifically focuses on screening for disorders such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
Results are typically presented in two categories: “Low Risk” or “High Risk”:
- A Low Risk result means the likelihood of the screened abnormalities being present in the fetus is low.
- A High Risk result means the probability of a chromosomal disorder is higher, but this is not considered a definitive diagnosis.
If the NIPT indicates that the fetus is at high risk for a chromosomal disorder, your healthcare provider may recommend diagnostic tests that provide a conclusive answer, such as:
- Amniocentesis: A procedure in which a small amount of amniotic fluid is taken from the uterus. This test can be performed after the 15th week of pregnancy.
- Chorionic Villus Sampling (CVS): A procedure in which cells are taken from the placenta and sent to a laboratory for analysis. It can be performed between weeks 10 and 13 of pregnancy.
It is important to discuss your NIPT results with your doctor to get all the necessary information to make an informed decision about the next steps.
Can NIPT results be wrong?
Although NIPT is highly accurate, it does not provide 100% certainty.
There can be false positive cases (a high-risk result when the fetus is actually healthy), due to factors such as:
- Genetic mosaicism
- Cellular variations in the placenta
- Or the presence of non-fetal DNA in the blood.
Therefore, a high-risk result should always be confirmed with a diagnostic invasive test like amniocentesis or CVS.
Is the NIPT test worth doing?
The decision to undergo NIPT or other prenatal genetic screenings is a personal one. Your healthcare provider can answer your questions, but ultimately, the choice is yours to determine how a genetic or chromosomal disorder would affect your life and family according to your circumstances.
The following questions may help you make your decision:
- How would I feel if the test result were positive?
- Would I consider having diagnostic tests like amniocentesis or CVS?
- Would I act differently if I knew the fetus had or was at risk for a genetic disorder?
- Would this make me feel sad or anxious, or would it help me prepare to care for the child?
- Would knowing this information help healthcare providers take better care of the child?
How does NIPT work from a scientific perspective?
During pregnancy, small fragments of the fetus’s cell-free DNA (cffDNA) pass into the mother’s bloodstream.
This cell-free fetal DNA makes up approximately 2–20% of the total DNA in the mother’s blood.
The laboratory analyzes this DNA using advanced sequencing techniques (Next-Generation Sequencing) to detect any abnormalities in the number or structure of chromosomes.
Does the NIPT test determine the baby’s gender?
Yes, the NIPT test can determine the fetal genderby analyzing the sex chromosomes and detecting whether the fetus is male or female. However, learning the sex is usually a secondary outcome of the analysis, and the mother is informed if she wishes to know. It is important to note that the primary purpose of the test is to screen for chromosomal abnormalities, not to determine sex.
In which cases should the NIPT test be performed?
Although NIPT is recommended for all pregnant women, it is particularly important in the following cases:
- Advanced maternal age (over 35 years).
- Abnormal biochemical screening test (blood test) markers.
- The presence of malformations or anomalies on an ultrasound scan.
- A family history of genetic diseases detectable through prenatal screenings.
- A parental history of numerical or structural chromosomal abnormalities.
- Exposure to teratogenic (birth-defect causing) or foetotoxic (fetus-harming) factors or infections.
- Any other risk factors determined by the doctor.
It is preferable for every mother to undergo NIPT if she wishes to ensure her baby’s health and have a peaceful pregnancy. However, this test should be performed exclusively under the supervision of accredited genetic assessment centers.
Are there other tests performed alongside NIPT?
Yes, there are additional tests that can be performed alongside NIPT, the most important of which are:
- First-trimester combined screening: Includes a nuchal translucency ultrasound and blood analyses to assess the risk of Down syndrome.
- Triple or Quad screen (Second trimester): Performed later to estimate the risks of certain genetic disorders and neural tube defects.
- If NIPT indicates a high risk, diagnostic tests such as amniocentesis or CVS may be recommended to confirm the diagnosis. When these tests are combined, a more comprehensive and accurate assessment of genetic risks during pregnancy can be obtained.
Can NIPT be performed at 14 weeks of pregnancy?
Yes, the test can be performed at any time after the 10th week of pregnancy.
What distinguishes NIPT from other traditional pregnancy tests?
NIPT was developed from previous non-invasive prenatal screenings like serum blood tests, as well as from surgical techniques. DNA-based molecular genetic studies have proven that the risk of certain fetal chromosomal trisomies can be determined from the mother’s blood using NIPT, making this test a practical and reliable method for genetic screening.
In contrast, procedures like chorionic villus sampling (CVS) or amniocentesis require intervention into the uterus, which increases the risk of miscarriage. NIPT carries no such risk for the fetus or the mother, as it requires no uterine intervention; it only requires drawing about 9 ml of the mother’s blood for testing.
Consequently, there is no risk of losing the fetus due to medical intervention with NIPT.
Advantages of NIPT compared to traditional screenings:
- Higher accuracy than traditional screenings like the Triple test and the Quad test.
- Relatively faster results (within 7–14 days).
- Completely safe for the mother and fetus, as it only requires a maternal blood sample.
- Reduces the need for invasive tests (like amniocentesis) unless the result is positive.
Turkey Healthcare Group stands out with a team of distinguished medical experts in Turkey, who always strive to provide the best healthcare services to patients.
If you are looking for exceptional healthcare or need medical consultation from top doctors, feel free to contact us.
We also invite you to view our leading medical staff and get to know their qualifications and experiences up close.
We are here to ensure you receive the best possible healthcare.
